|
|
 |
|
Viewing report
|
|
|
|
Erythropoiesis-Stimulating Agents in the Treatment of Chemotherapy Induced Anemia and Anemia in Chronic Kidney Disease in the US
GlobalData, Aug 2011, Pages: 6
Erythropoiesis-Stimulating Agents in the Treatment of Chemotherapy Induced Anemia and Anemia in Chronic Kidney Disease in the US
Summary
GlobalData’s report “Erythropoiesis-Stimulating Agents in the Treatment of Chemotherapy Induced Anemia and Anemia in Chronic Kidney Disease in the US“ provide key features of the Erythropoiesis-Stimulating Agents in the Treatment of Anemia
Scope
The scope of the report includes -
- Advantage of Erythropoiesis-Stimulating Agents in the Treatment of Anemia
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop business strategies and perform superior market quantification analysis by
- Understanding the trends shaping and driving the global diabetes market .
- Understanding treatment preferences of physicians in disease state and across treatment flow.
|
|
|
|
